One-Time CAR-T Leader Juno Shows Off Promising New Clinical Data Post author:Sam Post published:November 1, 2017 Post category:BioPharma The company submitted 15 abstracts to be presented at the upcoming ASH Conference. Source: BioSpace You Might Also Like Seattle Genetics Commences Dosing in Early-Stage Multiple Myeloma Trial March 6, 2018 Mass Layoffs Hit Ariad Employees After Takeda's $5.2 Billion Buyout Deal March 29, 2017 Bay Area's Depomed Craters as New CEO, Directors are Named in Deal With Activist Investor March 28, 2017
Bay Area's Depomed Craters as New CEO, Directors are Named in Deal With Activist Investor March 28, 2017
